about
Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus ProductionAnalysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolutionConformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released VirusesFlunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.Hepatitis C Virus Stimulates Murine CD8α-Like Dendritic Cells to Produce Type I Interferon in a TRIF-Dependent MannerIon Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronavirusesHepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.Immune protection against reinfection with nonprimate hepacivirus.cGAS-Mediated Innate Immunity Spreads Intercellularly through HIV-1 Env-Induced Membrane Fusion Sites.Protein Interactions during the Flavivirus and Hepacivirus Life Cycle.Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases.Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions.[Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E].Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity.Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy.Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horses.Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry.Apolipoprotein E polymorphisms and their protective effect on hepatitis E virus replication.Hepatitis C virus plays hide and seek with neutralizing antibodies.Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease.CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLBThe Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral InhibitorFunctional and immunogenic characterization of diverse HCV glycoprotein E2 variantsCohort profile: The LoewenKIDS Study – life-course perspective on infections, the microbiome and the development of the immune system in early childhoodCharacterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry FactorsLabyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated VirolysisHepatitis C VirusA central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitorsHepatitis C Virus Entry: Protein Interactions and Fusion Determinants Governing Productive Hepatocyte InvasionSynthesis of 4'/5'-Spirocyclopropanated Uridine and d-Xylouridine Derivatives and Their Activity against the Human Respiratory Syncytial Virus
P50
Q26801759-2A4AD2A4-B8A4-4DE2-A2FA-DBA5831BD4DCQ27314827-CEC67DB9-0BAC-4E77-8EC7-5CA29484DF99Q28659586-CA671C9B-5821-4E0A-A1B9-98CCF09BE36EQ33691856-A26A85AA-2950-4308-9C0A-CCBC94628103Q33890011-5AA71E8F-409E-4211-8BAB-8256F6332E00Q35727227-45F6D68E-A229-49A6-AD2A-B0A2899B13EFQ35739094-4BC8F715-5931-4670-A771-F23EDE3D56D6Q36069295-C7A5E968-B741-4064-85ED-0D58972D7206Q36878871-34FCE90D-070A-4BD9-9E2A-D7BFDA904A66Q37352688-60D1CE74-2551-473B-B880-7FC8A02A0D96Q37415364-B4501248-2463-4678-AB07-35B88758AD60Q37730141-AD946C6E-BA5C-489D-87FF-DDB3C011A5B3Q38741351-817B8BE3-0804-4B39-897D-DADE8BF4B80CQ38771712-75B5C03C-9D85-40DF-8AE4-FEB4D8B39EEAQ38964215-5F02C1C7-57C8-4CA2-9DB8-2733EBF1478DQ38997064-26871BCD-1D38-4BF1-B76A-B735268B7BC7Q39000841-CEAF1696-4275-475C-803A-84398CBBCBA0Q39068693-83625507-14BA-4C6D-95AA-BA632D9CECA1Q40141933-5C95415F-BA01-4E35-B850-43AEC4BAD9C5Q40153413-CC1A66A2-BC75-4890-854E-E9810E3D57E9Q40229725-D2A65210-698D-4CFF-BA85-0E5C40AEA1CDQ40382054-05FB875F-EACB-4048-9CA7-492D98F6D196Q40913679-7EF3F1A0-3B53-46FA-AD85-D9C3B99D2617Q41033867-D8666157-8EF5-49EE-A9C4-2EEA0EEA18ACQ41742523-DE914410-E69F-4D7B-9CE9-A41E60A65A5FQ41935207-F3FB694F-2C4D-4A00-A966-1BD53926E5F3Q45333813-E278EA73-9E2D-4EDE-9E85-E2114FB44251Q45333982-A4BCA20E-4D30-4FC0-BDB7-6823A5AA4578Q49955766-441D0526-C41D-49DE-9AEE-E931F350FDCEQ54231580-7E76CA49-5C0D-4DAD-9CD9-81970C70273EQ56360968-D3B1E577-6F4E-40BB-A557-B27C74003041Q57789690-8E001297-939A-44B4-921D-7FB2F6896E7CQ59350894-7AC5673A-7A0C-4F4B-9FBF-3DAD3E7DB955Q62813916-0B903AB8-0AA8-4DA2-8A74-93BE80E24D5CQ64078182-132AA3E3-F6E5-4A16-AC0C-09543B746B3EQ91011119-B7589714-4F4E-4AA6-9EF4-7CB3C2739D5EQ91311249-5958A69E-F764-4558-B16A-9BC0CFE89628Q91623209-C2E71CE7-7CFC-416D-A652-41E2CBFA562EQ92707735-FF954014-5DAA-42AC-9C19-69D35AC2DAE5Q92746159-AC406B0D-CFC2-4329-A0B6-3DBCA6A1915B
P50
description
researcher
@en
wetenschapper
@nl
name
Thomas Pietschmann
@en
Thomas Pietschmann
@nl
type
label
Thomas Pietschmann
@en
Thomas Pietschmann
@nl
prefLabel
Thomas Pietschmann
@en
Thomas Pietschmann
@nl
P31
P496
0000-0001-6789-4422